Annexon Submits Tanruprubart Marketing Authorization Application to the European Medicines Agency for Guillain-Barré Syndrome

(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today ...
Family Destinations Guide

The Gorgeous Botanical Garden In Michigan That You’ve Probably Never Heard Of

Hidden behind stately stone walls in Bloomfield Hills lies a horticultural wonderland that feels like stepping into a European fairy tale—complete with reflecting pools, marble sculptures, and gardens ...
Family Destinations Guide

People Drive From All Over New Jersey To Explore This Gorgeous Historic Town

FitzRandolph Gate marks the official entrance to the university from Nassau Street, its ornate ironwork standing open since ...
Ophthalmology Times

FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy

The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...
Healio

FDA fast tracks CTx001 for geographic atrophy

The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...